.png)
PAK BioSolutions provides comprehensive solutions for end-to-end continuous manufacture of biopharmaceuticals. The company aims to meet growing demand for automated equipment and consumables in this space to enable implementation of continuous processes in both laboratory and GMP facilities.
The company’s key technologies include the Pilot PAK, an automated system that operates four continuous purification stages simultaneously, and a solid single-use flow kit that is used with the system. PAK BioSolutions was awarded its first patent on March 31, 2021 for a “Therapeutic Protein Flow Kit for a Continuous Purification System” by the U.S. Patent and Trademark Office (USPTO), U.S. patent 10,981,950.
In addition to the company’s product offerings, consulting services are provided. PAK’s engineers are available to provide technical seminars, perform individualized technical and business case evaluations, and assist customers with implementation of continuous manufacturing processes.